Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study
- PMID: 32633729
- PMCID: PMC7343511
- DOI: 10.18632/aging.103372
Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study
Abstract
Background: The World Health Organization has declared coronavirus disease 2019 (COVID-19) a public health emergency of global concern. Updated analysis of cases might help identify the risk factors of illness severity.
Results: The median age was 63 years, and 44.9% were severe cases. Severe patients had higher APACHE II (8.5 vs. 4.0) and SOFA (2 vs. 1) scores on admission. Among all univariable parameters, lymphocytes, CRP, and LDH were significantly independent risk factors of COVID-19 severity. LDH was positively related both with APACHE II and SOFA scores, as well as P/F ratio and CT scores. LDH (AUC = 0.878) also had a maximum specificity (96.9%), with the cutoff value of 344.5. In addition, LDH was positively correlated with CRP, AST, BNP and cTnI, while negatively correlated with lymphocytes and its subsets.
Conclusions: This study showed that LDH could be identified as a powerful predictive factor for early recognition of lung injury and severe COVID-19 cases.
Methods: We extracted data regarding 107 patients with confirmed COVID-19 from Renmin Hospital of Wuhan University. The degree of severity of COVID-19 patients (severe vs. non-severe) was defined at the time of admission according to American Thoracic Society guidelines for community acquired pneumonia.
Keywords: COVID-19; coronavirus disease 2019; inflammatory response; lactate dehydrogenase (LDH); lung injury.
Conflict of interest statement
Figures
Similar articles
-
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.Clin Chim Acta. 2020 Oct;509:135-138. doi: 10.1016/j.cca.2020.06.012. Epub 2020 Jun 9. Clin Chim Acta. 2020. PMID: 32531257 Free PMC article.
-
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895. JAMA Netw Open. 2020. PMID: 32492165 Free PMC article.
-
Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.Aging (Albany NY). 2020 Aug 14;12(15):15670-15681. doi: 10.18632/aging.103770. Epub 2020 Aug 14. Aging (Albany NY). 2020. PMID: 32805722 Free PMC article.
-
New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.J Med Internet Res. 2020 Sep 18;22(9):e20548. doi: 10.2196/20548. J Med Internet Res. 2020. PMID: 32540837 Free PMC article.
-
Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis.Am J Emerg Med. 2020 Sep;38(9):1722-1726. doi: 10.1016/j.ajem.2020.05.073. Epub 2020 May 27. Am J Emerg Med. 2020. PMID: 32738466 Free PMC article. Review.
Cited by
-
Hematological and Biochemical Laboratory Parameters in COVID-19 Patients: A Retrospective Modeling Study of Severity and Mortality Predictors.Biomed Res Int. 2023 Nov 18;2023:7753631. doi: 10.1155/2023/7753631. eCollection 2023. Biomed Res Int. 2023. PMID: 38027038 Free PMC article.
-
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.Front Immunol. 2023 Oct 18;14:1270081. doi: 10.3389/fimmu.2023.1270081. eCollection 2023. Front Immunol. 2023. PMID: 37920468 Free PMC article.
-
Vitamin D status in hospitalized COVID‑19 patients is associated with disease severity and IL-5 production.Virol J. 2023 Sep 13;20(1):212. doi: 10.1186/s12985-023-02165-1. Virol J. 2023. PMID: 37705107 Free PMC article.
-
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.Sci Rep. 2023 Aug 7;13(1):12784. doi: 10.1038/s41598-023-39681-7. Sci Rep. 2023. PMID: 37550377 Free PMC article. Clinical Trial.
-
Factors Affecting Hospitalization Length and in-Hospital Death Due to COVID-19 Infection in Saudi Arabia: A Single-Center Retrospective Analysis.Int J Gen Med. 2023 Aug 1;16:3267-3280. doi: 10.2147/IJGM.S418243. eCollection 2023. Int J Gen Med. 2023. PMID: 37546239 Free PMC article.
References
-
- World Health Organization. Coronavirus disease (COVID-19) outbreak 2020. https://www.who.int)
-
- National Health Commission of the People’s Republic of China home page. 2020 http://www.nhc.gov.cn
-
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: a descriptive study. Lancet. 2020; 395:507–13. 10.1016/S0140-6736(20)30211-7 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
